Arima Genomics Announces Appointment of Genomics Leader Raees Ebrahim as Vice President of Sales

Carlsbad, Calif.- July 22, 2024 – Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights that will empower researchers and clinicians to improve human health, today announced the appointment of Raees Ebrahim to the position of Vice President of Sales. In this role, Raees will be responsible for executing strategic sales initiatives, nurturing relationships with key stakeholders in both research and clinical laboratories, driving market expansion, and supporting the overall adoption of 3D genomics technology.

“Now is a transformative time to join the leading 3D genomics tools company as the scientific and clinical research communities embrace these technologies for unlocking new insights about the genetic and epigenetic factors that drive human health and other fields of biological discovery,” said Raees Ebrahim. “Technologies developed by Arima Genomics will only become more crucial to our collective understanding of diverse fields from human evolution to cancer biology and beyond.”

Raees brings over 20 years of leadership experience within sales and business development across research-oriented and clinically focused companies. Most recently, he was Vice President of Sales at ChromaCode, Inc., responsible for driving commercial partnerships, overseeing the sales pipeline, and aligning sales initiatives with company goals; (specifically on achieving reimbursement). Raees previously held senior leadership roles at Preferred Medicine, Inc., BioReference Laboratories, Sound Physicians, and Natera. He holds an M.B.A. in Finance from the University of Rochester and a B.S. from the University of California, Riverside.

“Raees’s extensive experience and proven success as a sales leader will be instrumental in advancing our mission to propel 3D genomics into more labs and integrate this technology into more translational and clinical settings,” said Siddarth Selvaraj, Ph.D., Chief Executive Officer of Arima Genomics. “We look forward to empowering more laboratories to adopt Arima Genomics technologies in the coming years.”

About Arima Genomics

Armia Genomics, Inc. is advancing human health and the life sciences by revealing comprehensive genomic insights. Researchers and clinicians use Arima Genomics’ innovative products and services to gain unparalleled access to the three-dimensional (3D) organization of the genome. This advanced technology enables improvements in human health through identification of biomarkers, an expanded understanding of disease mechanisms, development of novel therapeutic approaches, and solutions for patient management. To learn more, visit www.arimagenomics.com and connect with us on X, LinkedIn, and YouTube.

Contacts

For media
Gwen Gordon
gwen@gwengordonpr.com

For general inquiries
Chris Roberts
chris@arimagenomics.com